Did medicare induce pharmaceutical innovation?

American Economic Review

Volumn 96, Issue 2, 2006, Pages 103-107

  Acemoglu, Daron ^a,b   Cutler, David ^b,c,d   Finkelstein, Amy ^a,b,e   Linn, Joshua ^f  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b NATIONAL BUREAU OF ECONOMIC RESEARCH   (United States)

^c HARVARD UNIVERSITY   (United States)

^d Littauer Center   (United States)

^e Littauer Center ^*  (United States)

^f UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; DRUG APPROVAL; DRUG INDUSTRY; ECONOMICS; FORECASTING; HUMAN; MASS COMMUNICATION; MEDICARE; PHARMACOECONOMICS; STATISTICS AND NUMERICAL DATA; TRENDS; UNITED STATES;

AGED; DIFFUSION OF INNOVATION; DRUG APPROVAL; DRUG INDUSTRY; ECONOMICS, PHARMACEUTICAL; FORECASTING; HUMANS; MEDICARE; UNITED STATES;

EID: 33744513659     PISSN: 00028282     EISSN: None     Source Type: Journal    
DOI: 10.1257/000282806777211766     Document Type: Conference Paper

References (11)

1. Acemoglu, Daron; Cutler, David; Finkelstein, Amy and Linn, Joshua. "Did Medicare Induce Pharmaceutical Innovation?" National Bureau of Economic Research, Inc., NBER Working Papers: (forthcoming).
2. Acemoglu, Daron and Linn, Joshua. "Market Size in Innovation: Theory and Evidence from the Pharmaceutical Industry." Quarterly Journal of Economics, 2004, 119(3), pp. 1049-90.
3. Cook, Benjamin; Landrum, Mary B. and Meara, Ellen. "The Impact of Medicare on Health Outcomes and Disparities among the Elderly." Unpublished Paper, 2005.
4. Cutler, David. Your money or your life: Strong medicine for America's health care system. New York: Oxford University Press, 2004.
5. Cutler, David M. and Kadiyala, Srikanth. "The Return to Biomedical Research: Treatment and Behavioral Effects," in Kevin M. Murphy and Robert H. Topel, eds., Measuring the gains from medical research: An economic approach. Chicago: University of Chicago Press, 2003, pp. 110-62.
6. DiMasi, Joseph A.; Hansen, Ronald W.; Grabowski, Henry G. and Lasagna, Louis. "Cost of Innovation in the Pharmaceutical Industry." Journal of Health Economics, 1991, 10(2). pp. 107-42.
7. Finkelstein, Amy. "Static and Dynamic Effects of Health Policy: Evidence from the Vaccine Industry." Quarterly Journal of Economics, 2004, 119(2), pp. 527-64.
8. Finkelstein, Amy. "The Aggregate Effects of Health Insurance: Evidence from the Introduction of Medicare." National Bureau of Economic Research, Inc., NBER Working Papers: No. 11619, 2005.
9. Finkelstein, Amy and McKnight, Robin. "What Did Medicare Do (and Was It Worth It)?" National Bureau of Economic Research, Inc., NBER Working Papers: No. 11609, 2005.
10. Lichtenberg, Frank R. "Public Policy and Innovation in the U.S. Pharmaceutical Industry," in Douglas Holtz-Eakin and Harvey S. Rosen, eds., Public policy and the economics of entrepreneurship. Cambridge, MA: MIT Press, 2004, pp. 83-113.
11. Wooldridge, Jeffrey M. "Distribution-Free Estimation of Some Nonlinear Panel Data Models." Journal of Econometrics, 1999, 90(1), pp. 77-97.